The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
This is the first update to the original CTS communication distributed on July 6th. As previously co...